Enkephalin
CAS 58822-25-6
Enkephalin (CAS 58822-25-6) is a pharmaceutical compound with 6 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Ki | 621.8800545454545 nM | 52 | - |
| - | IC50 | 325.008775 nM | 37 | - |
| - | EC50 | 224.89333333333332 nM | 16 | - |
| - | Potency | 1 | 2 | - |
| - | Potency | 33321.9 nM | 2 | - |
| - | Kd | 7.1 nM | 1 | - |
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| δ receptor Oprd1 |
Full agonist | 8.4 pKi | 8114680 |
| δ receptor OPRD1 |
Full agonist | 8.7 pKi | 9686407 |
| κ receptor Oprk1 |
Full agonist | 6.0 pKi | 8234341 |
| μ receptor OPRM1 |
Partial agonist | 8.1 pKi | 9686407 |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Enkephalin used for in pharmaceutical contexts?
Enkephalin (CAS 58822-25-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Enkephalin?
No adverse-event association or SIDER side-effect rows are rendered for Enkephalin in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Enkephalin also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for sh-Pentapeptide-5 with EU status "permitted".
What clinical phase is Enkephalin in?
No phase 1-4 clinical development badge is rendered for Enkephalin because the matched compound identifier rows do not contain a max-phase value.